IRIS Accounts Production v24.1.0.578 SC708094 director 1.1.23 31.12.23 31.12.23 false true false false true false Ordinary 1.00000 Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhSC7080942022-12-31SC7080942023-12-31SC7080942023-01-012023-12-31SC7080942021-08-30SC7080942021-08-312022-12-31SC7080942022-12-31SC708094ns15:Scotland2023-01-012023-12-31SC708094ns14:PoundSterling2023-01-012023-12-31SC708094ns10:Director12023-01-012023-12-31SC708094ns10:PrivateLimitedCompanyLtd2023-01-012023-12-31SC708094ns10:SmallEntities2023-01-012023-12-31SC708094ns10:AuditExempt-NoAccountantsReport2023-01-012023-12-31SC708094ns10:SmallCompaniesRegimeForDirectorsReport2023-01-012023-12-31SC708094ns10:SmallCompaniesRegimeForAccounts2023-01-012023-12-31SC708094ns10:FullAccounts2023-01-012023-12-31SC708094ns10:OrdinaryShareClass12023-01-012023-12-31SC708094ns10:OrdinaryShareClass22023-01-012023-12-31SC708094ns5:CurrentFinancialInstruments2023-12-31SC708094ns5:CurrentFinancialInstruments2022-12-31SC708094ns5:ShareCapital2023-12-31SC708094ns5:ShareCapital2022-12-31SC708094ns5:RetainedEarningsAccumulatedLosses2023-12-31SC708094ns5:RetainedEarningsAccumulatedLosses2022-12-31SC708094ns10:RegisteredOffice2023-01-012023-12-31SC708094ns5:FurnitureFittings2022-12-31SC708094ns5:FurnitureFittings2023-01-012023-12-31SC708094ns5:FurnitureFittings2023-12-31SC708094ns5:FurnitureFittings2022-12-31SC708094ns10:OrdinaryShareClass12023-12-31SC708094ns10:OrdinaryShareClass22023-12-31SC7080941ns10:Director12022-12-31SC7080941ns10:Director12021-08-30SC7080941ns10:Director12023-01-012023-12-31SC7080941ns10:Director12021-08-312022-12-31SC7080941ns10:Director12023-12-31SC7080941ns10:Director12022-12-31
REGISTERED NUMBER: SC708094 (Scotland)















Unaudited Financial Statements for the Year Ended 31st December 2023

for

Saarib Medical Ltd

Saarib Medical Ltd (Registered number: SC708094)






Contents of the Financial Statements
for the Year Ended 31st December 2023




Page

Balance Sheet 1

Notes to the Financial Statements 2


Saarib Medical Ltd (Registered number: SC708094)

Balance Sheet
31st December 2023

31.12.23 31.12.22
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 3,671 287

CURRENT ASSETS
Cash at bank 23,135 54,094

CREDITORS
Amounts falling due within one year 5 6,249 33,469
NET CURRENT ASSETS 16,886 20,625
TOTAL ASSETS LESS CURRENT
LIABILITIES

20,557

20,912

PROVISIONS FOR LIABILITIES 712 72
NET ASSETS 19,845 20,840

CAPITAL AND RESERVES
Called up share capital 6 5 5
Retained earnings 19,839 20,836
SHAREHOLDERS' FUNDS 19,844 20,841

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st December 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st December 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 20th August 2024 and were signed by:





Dr A Raza - Director


** STATEMENT OF FINANCIAL POSITION - CURRENT YEAR - DOES NOT BALANCE - PLEASE CHECK THAT ALL POSTINGS HAVE BEEN MADE TO ACCOUNTS USED ON LIMITED COMPANY REPORTS
** STATEMENT OF FINANCIAL POSITION - LAST YEAR - DOES NOT BALANCE - PLEASE CHECK THAT ALL POSTINGS HAVE BEEN MADE TO ACCOUNTS USED ON LIMITED COMPANY REPORTS

Saarib Medical Ltd (Registered number: SC708094)

Notes to the Financial Statements
for the Year Ended 31st December 2023

1. COMPANY INFORMATION

Saarib Medical Ltd is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address are as below:

Registered number: SC708094

Registered office: 62 Kyle Wynd
Newton Mearns
Glasgow
G77 5XJ

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Revenue from the provision of professional services is recognised on delivery of the service.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Tangible fixed assets are included at cost less depreciation and impairment. Depreciation has been computed to write off the cost of tangible fixed assets over their expected useful life.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2022 - 2 ) .

Saarib Medical Ltd (Registered number: SC708094)

Notes to the Financial Statements - continued
for the Year Ended 31st December 2023

4. TANGIBLE FIXED ASSETS
Fixtures
and
fittings
£   
COST
At 1st January 2023 299
Additions 4,612
At 31st December 2023 4,911
DEPRECIATION
At 1st January 2023 12
Charge for year 1,228
At 31st December 2023 1,240
NET BOOK VALUE
At 31st December 2023 3,671
At 31st December 2022 287

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.23 31.12.22
£    £   
Tax 4,719 6,929
Directors' current accounts 642 25,721
Accrued expenses 888 819
6,249 33,469

6. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.12.23 31.12.22
value: £    £   
4 Ordinary £1 5 5
1 Ordinary £1 - -
5 5

The Ordinary shares confer on the holders the right to vote upon any resolution proposed at any general meeting of the company.

The Ordinary Shares rank pari passu in respect of dividend and capital distribution rights.

Saarib Medical Ltd (Registered number: SC708094)

Notes to the Financial Statements - continued
for the Year Ended 31st December 2023

7. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the year ended 31st December 2023 and the period ended 31st December 2022:

31.12.23 31.12.22
£    £   
Dr A Raza
Balance outstanding at start of year (25,721 ) -
Amounts advanced 67,789 5
Amounts repaid (42,710 ) (25,726 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (642 ) (25,721 )

The loan is repayable on demand and no interest was charged during the year.

8. ULTIMATE CONTROLLING PARTY

The controlling party is Dr A Raza.